1. Home
  2. CDNA vs SFL Comparison

CDNA vs SFL Comparison

Compare CDNA & SFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • SFL
  • Stock Information
  • Founded
  • CDNA 1998
  • SFL 2003
  • Country
  • CDNA United States
  • SFL Bermuda
  • Employees
  • CDNA N/A
  • SFL N/A
  • Industry
  • CDNA Medical Specialities
  • SFL Marine Transportation
  • Sector
  • CDNA Health Care
  • SFL Consumer Discretionary
  • Exchange
  • CDNA Nasdaq
  • SFL Nasdaq
  • Market Cap
  • CDNA 1.1B
  • SFL 1.0B
  • IPO Year
  • CDNA 2014
  • SFL N/A
  • Fundamental
  • Price
  • CDNA $18.90
  • SFL $7.60
  • Analyst Decision
  • CDNA Buy
  • SFL Strong Buy
  • Analyst Count
  • CDNA 8
  • SFL 2
  • Target Price
  • CDNA $29.43
  • SFL $14.50
  • AVG Volume (30 Days)
  • CDNA 661.3K
  • SFL 1.5M
  • Earning Date
  • CDNA 04-30-2025
  • SFL 05-13-2025
  • Dividend Yield
  • CDNA N/A
  • SFL 14.21%
  • EPS Growth
  • CDNA N/A
  • SFL 52.99
  • EPS
  • CDNA 0.93
  • SFL 1.01
  • Revenue
  • CDNA $333,785,000.00
  • SFL $894,061,000.00
  • Revenue This Year
  • CDNA $13.33
  • SFL N/A
  • Revenue Next Year
  • CDNA $15.07
  • SFL $5.49
  • P/E Ratio
  • CDNA $20.32
  • SFL $7.65
  • Revenue Growth
  • CDNA 19.07
  • SFL 20.12
  • 52 Week Low
  • CDNA $7.42
  • SFL $6.78
  • 52 Week High
  • CDNA $34.84
  • SFL $14.62
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 50.38
  • SFL 41.42
  • Support Level
  • CDNA $15.78
  • SFL $6.97
  • Resistance Level
  • CDNA $20.13
  • SFL $7.78
  • Average True Range (ATR)
  • CDNA 1.37
  • SFL 0.37
  • MACD
  • CDNA 0.24
  • SFL 0.02
  • Stochastic Oscillator
  • CDNA 71.72
  • SFL 52.90

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

About SFL SFL Corporation Ltd

SFL Corp Ltd is an international ship-owning and chartering company. The company is engaged in transporting crude oil and oil products, dry bulk and containerized cargoes, freight of rolling cargo, and offshore drilling and related activities.

Share on Social Networks: